SCHW — The Charles Schwab Corporation

The Q2 2026 beat (adjusted EPS $1.62 vs. consensus around $1.54), record daily average trades of 11.9 million, and $120 billion of core net new assets have kept the analyst community constructive: roughly 29 Buy, 19 Hold, 3 Sell with a consensus target of $126.50. The stock is near its 52-week high, but the -1.2% move on 2026-08-27 and RSI at 51.25 show the tape is consolidating rather than euphoric.

The trend is clearly accelerating. Revenue climbed from $6.4B in Q3 2023 to $6.5B in Q1 2024, then $7.0B in Q3 2025, $7.3B in Q1 2026 and $8.5B in Q2 2026; Q2 2026 revenue was +25% YoY versus roughly +9% in Q2 2025. Diluted EPS rose from $0.56 in Q3 2023 to $1.54 in Q2 2026, and operating margin expanded from ~22% to ~43% over the same period. That margin expansion is structural/TD-integration-related, although the 16.7% QoQ revenue jump in Q2 2026 contains some above-trend trading and market activity.

As of 2026-08-27, valuation is fair-to-attractive. The stock trades at 19.6x trailing EPS of $5.82 and roughly 16.6x the next-fiscal-year EPS estimate of $6.50, a clear discount to its 5-year average P/E of 25.25. Price-to-sales of 6.26 is also slightly below the 5-year average of 6.38, and the 0.41 PEG ratio looks inexpensive. On a P/B basis (3.76x) it is not a deep-value stock, but versus its own history and near-term growth it is not expensive.

At $108.05, the stock is not pricing in overly optimistic growth: it is paying about 16.6x forward EPS, and the consensus $126.50 target is only ~19.5x the same $6.50 estimate. If the margin recovery continues and EPS reaches $6.50, there is roughly 15-20% upside; if trading volumes fade or rates compress NII, the first major support is near $103 (50-day SMA) and then $97 (200-day SMA). This is a reasonable-risk setup, but not a can't-miss entry point.

As of 2026-08-27, RSI(14) was 51.25—dead-center neutral. Price was 1.1% below the 20-day SMA, 4.9% above the 50-day SMA, and 11.4% above the 200-day SMA, so the longer-term trend is up while short-term momentum has stalled after the run toward $114.53. The practical read: don't chase; look for an entry closer to the 50-day near $103 or the 200-day near $97.

• Fed rate path: funding costs have normalized but the direction of rates still drives net interest income and client cash sorting behavior.
• Equity market sensitivity: with over $13 trillion in client assets, a broad market drawdown would directly reduce asset-based fees and trading revenue.
• RIA custody moat: Schwab's >40% share in RIA custody provides sticky, durable organic asset growth that buffers cyclical dips.
• Competitive pressure: zero-commission brokers, crypto-native platforms, and AI-native advice tools continue to push fee rates lower industry-wide.
• AI/technology investment: artificial intelligence is both a margin opportunity and a required capex/competition battleground.

• Q3 2026 earnings in mid-October: the first real test of whether Q2's revenue and margin step-up is sustainable.
• Schwab IMPACT 2026 conference: AI and advisor-tool announcements could reinforce asset-gathering momentum.
• Expanded crypto offering (Solana, Avalanche, ChainLink) could drive engagement and net new assets.
• Any Fed policy signal on rates would be a catalyst—cuts would pressure NII, while a stable normalization path helps cash sorting.

• Market downturn: a sustained equity selloff would hit trading volumes, asset-based fees, and sentiment all at once.
• Rate shocks: rapid or unexpected rate cuts could compress asset yields before funding costs adjust, squeezing NII.
• Competition/fee compression: Fidelity, Vanguard, Robinhood and crypto-native platforms keep eroding pricing power.
• Operational and regulatory risk on a $13 trillion custody platform—cyber incidents or compliance failures would be costly.

Schwab is a high-quality, market-dominant financial franchise with accelerating revenue, expanding margins, and a valuation below its own five-year averages. The deterministic score calls it just 'Fair' and the stock is not deeply discounted, so the right move for new money is to be patient and buy on a pullback toward $103 or lower; existing holders have a reasonable long-term compounder. This is an assessment of the securities, not personalized advice.

I applied a justified forward P/E of 20.0x to next-fiscal-year consensus EPS of $6.50 to get $130.00; the 20x multiple is a discount to SCHW's 5-year average P/E of 25.25 and a modest premium to today's 19.6x trailing multiple, justified by ~12% expected EPS growth, 43% operating margins, and the RIA custody moat, while still reflecting rate/market cyclicality risk.